Sutro Biopharma STRO
NASDAQ STRO
$20.08 -0.46 (-2.24%)
As of: Sep 4, 2026 · 2:33 PM EDT

Sutro Biopharma (STRO) Property, Plant & Equipment (Net) (2017 - 2026)

Analysis

Sutro Biopharma (STRO) Property, Plant & Equipment (Net) (2017 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 138.77 Bn 130.92 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 85.51 Bn 77.52 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.20 Bn 53.06 Bn 52.00 Mn 2.06 Bn
5 Revolution Medicines 44.04 Bn 44.04 Bn - 34.61 Mn
6 BeOne Medicines 39.99 Bn 34.89 Bn 1.53 Bn 1.64 Bn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn 554.14 Mn
8 Royalty Pharma 28.40 Bn 27.56 Bn - -
9 Insmed 27.44 Bn 26.28 Bn 358.27 Mn 107.22 Mn
10 Sutro Biopharma 332.26 Mn 167.91 Mn - 8.36 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.36 Mn
Dec 31, 2025 10.65 Mn
Sep 30, 2025 13.35 Mn
Jun 30, 2025 14.98 Mn
Mar 31, 2025 16.80 Mn
Dec 31, 2024 18.19 Mn
Sep 30, 2024 19.00 Mn
Jun 30, 2024 19.41 Mn
Mar 31, 2024 20.63 Mn
Dec 31, 2023 21.94 Mn
Sep 30, 2023 22.34 Mn
Jun 30, 2023 23.64 Mn
Mar 31, 2023 24.03 Mn
Dec 31, 2022 24.62 Mn
Sep 30, 2022 24.28 Mn
Jun 30, 2022 23.60 Mn
Mar 31, 2022 23.29 Mn
Dec 31, 2021 22.55 Mn
Sep 30, 2021 23.32 Mn
Jun 30, 2021 18.67 Mn